Atopic dermatitis (eczema) trials in Italy

In Italy 16 Also abroad 255

10 of 16 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 3Active, not recruiting
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Where
Ancona, Brescia, Padova, Rome
Age
6 months to 11 years
People
195 worldwide
Run by
LEO Pharma
See details and how to joinNCT06311682 · EU 2023-503630-44-00
Phase 2Taking people
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Where
Ancona, Ferrara, Pisa
Age
18 years to 100 years
People
224 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00
Phase 3Not yet taking people in Italy
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Where
Ancona, Catania, Florence, Milan, Naples, Pisa, Rome, Rozzano
Age
12 years and over
People
510 worldwide
Run by
Nektar Therapeutics
See details and how to joinNCT07711418 · EU 2025-525129-11-00
No phaseTaking people
Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic Dermatitis
Where
Roma
Age
1 week to 5 months
People
64
Run by
University of Roma La Sapienza
See details and how to joinNCT07754968
Phase 2Not yet taking people in Italy
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Where
Ancona, Brescia, Catania, Genoa, Novara, Rome, Trieste
Age
18 years and over
People
200 worldwide
Run by
Corvus Pharmaceuticals, Inc.
See details and how to joinNCT07441395 · EU 2025-524384-20-00
No phaseTaking people
Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases
Where
Bologna, Roma
Age
18 years and over
People
280
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06529913
No phaseTaking people
CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis
Where
Roma
Age
18 years to 99 years
People
98
Run by
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
See details and how to joinNCT07204561
Phase 3Completed
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Where
Arezzo, Florence, Parma, Pisa
Age
18 years and over
People
277 worldwide
Run by
medac GmbH
See details and how to joinNCT06239311 · EU 2023-504443-13-00
No phaseTaking people
Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters
Where
Milan, Verona, Voghera
Age
6 months to 65 years
People
90
Run by
Biokosmes Srl
See details and how to joinNCT07056569
No phaseTaking people
Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics
Where
Rome
Age
18 years to 65 years
People
40
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06884163